Exp Clin Endocrinol Diabetes 2009; 117(6): 266-273
DOI: 10.1055/s-0028-1102942
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Mutations in the Melanocortin 4 Receptor (MC4R) Gene in Obese Patients in Norway

T. Wangensteen 1 , M. L. Pollestad Kolsgaard 2 , M. Mattingsdal 3 , G. Joner 2 , S. Tonstad 4 , D. Undlien 5 , L. Retterstol 1
  • 1Department of Medical Genetics, Ullevål University Hospital, Oslo, Norway
  • 2Department of Pediatrics, Ullevål University Hospital, Oslo, Norway
  • 3Department of Medical Informatics, Rikshospitalet-Radiumhospitalet, Oslo, Norway
  • 4Department of Preventive Cardiology, Ullevål University Hospital, Oslo, Norway
  • 5Institute of Medical Genetics, University of Oslo, Oslo, Norway
Further Information

Publication History

received 11.09.2008 first decision 13.10.2008

accepted 29.10.2008

Publication Date:
19 March 2009 (online)

Abstract

Background: Mutations in the melanocortin 4 receptor (MC4R) gene are the most frequent cause of monogenic forms of obesity, but the reported prevalences of mutations in obese individuals diverge, varying from 0.2 to 5.8%.

Objective: The aim of this study was to assess the prevalence of MC4R mutations in obese children and adults residing in Norway.

Subjects and Methods:We sequenced the coding region of MC4R in 1 027 obese patients. Among these, were 644 adults with a BMI >35 kg/m2 and 383 children with a body weight >97.5 percentile for height. Identified mutations were analyzed by family studies and a bioinformatic approach including comparative sequence analysis and prediction of impact on transmembrane helix and three dimensional structure.

Results: Nine mutations were identified, of which four were novel and five previously described. The prevalence of MC4R mutations was 1.6% in pediatric and 0.8% in adult patients. All four novel mutations, I69R, M79I, I195S, and M200del were identified among pediatric patients. M79I was found in an ethnic Norwegian patient, while the rest were identified in second generation immigrants. The previously described mutations Y35X/D37V, V95I, T150I, R236C and V253I were identified in one pediatric and five adult patients. None of the adult patients reported childhood onset of obesity. The M200del mutation was found in a homozygous state, while the rest were heterozygous.

Conclusion: MC4R mutations are not a common cause of obesity in Norway and screening of obese patients does not appear to be warranted. The results are consistent with results from previous studies.

References

  • 1 Branson R, Potoczna N, Kral JG. et al . Binge eating as a major phenotype of melanocortin 4 receptor gene mutations.  N Engl J Med. 2003;  348 ((12)) 1096-1103
  • 2 Buono P, Pasanisi F, Nardelli C. et al . Six novel mutations in the proopiomelanocortin and melanocortin receptor 4 genes in severely obese adults living in southern Italy.  Clin Chem. 2005;  51 ((8)) 1358-1364
  • 3 Cole TJ, Bellizzi MC, Flegal KM. et al . Establishing a standard definition for child overweight and obesity worldwide: international survey.  BMJ. 2000;  320 ((7244)) 1240-1243
  • 4 Farooqi IS, Keogh JM, Yeo GS. et al . Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.  N Engl J Med. 2003;  348 ((12)) 1085-1095
  • 5 Farooqi IS, Yeo GS, Keogh JM. et al . Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency.  J Clin Invest. 2000;  106 ((2)) 271-279
  • 6 Gormally J, Black S, Daston S. et al . The assessment of binge eating severity among obese persons.  Addict Behav. 1982;  7 ((1)) 47-55
  • 7 Govaerts C, Srinivasan S, Shapiro A. et al . Obesity-associated mutations in the melanocortin 4 receptor provide novel insights into its function.  Peptides. 2005;  26 ((10)) 1909-1919
  • 8 Gu W, Tu Z, Kleyn PW. et al . Identification and functional analysis of novel human melanocortin-4 receptor variants.  Diabetes. 1999;  48 ((3)) 635-639
  • 9 Hebebrand J, Geller F, Dempfle A. et al . Binge-eating episodes are not characteristic of carriers of melanocortin-4 receptor gene mutations.  Mol Psychiatry. 2004;  9 ((8)) 796-800
  • 10 Hinney A, Bettecken T, Tarnow P. et al . Prevalence, spectrum, and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany.  J Clin Endocrinol Metab. 2006;  91 ((5)) 1761-1769
  • 11 Hinney A, Hohmann S, Geller F. et al . Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity.  J Clin Endocrinol Metab. 2003;  88 ((9)) 4258-4267
  • 12 Hinney A, Schmidt A, Nottebom K. et al . Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans.  J Clin Endocrinol Metab. 1999;  84 ((4)) 1483-1486
  • 13 Hofbauer KG, Nicholson JR. Pharmacotherapy of obesity.  Exp Clin Endocrinol Diabetes. 2006;  114 ((9)) 475-484
  • 14 Jacobson P, Ukkola O, Rankinen T. et al . Melanocortin 4 receptor sequence variations are seldom a cause of human obesity: the Swedish Obese Subjects, the HERITAGE Family Study, and a Memphis cohort.  J Clin Endocrinol Metab. 2002;  87 ((10)) 4442-4446
  • 15 Larsen LH, Echwald SM, Sorensen TI. et al . Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity.  J Clin Endocrinol Metab. 2005;  90 ((1)) 219-224
  • 16 Lee YS, Poh LK, Kek BL. et al . Novel melanocortin 4 receptor gene mutations in severely obese children.  Clin Endocrinol (Oxf). 2008;  68 ((4)) 529-535
  • 17 Lubrano-Berthelier C, Cavazos M, Le SC. et al . The human MC4R promoter: characterization and role in obesity.  Diabetes. 2003a;  52 ((12)) 2996-3000
  • 18 Lubrano-Berthelier C, Dubern B, Lacorte JM. et al . Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating.  J Clin Endocrinol Metab. 2006;  91 ((5)) 1811-1818
  • 19 Lubrano-Berthelier C, Durand E, Dubern B. et al . Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations.  Hum Mol Genet. 2003b;  12 ((2)) 145-153
  • 20 Marti A, Corbalan MS, Forga L. et al . A novel nonsense mutation in the melanocortin-4 receptor associated with obesity in a Spanish population.  Int J Obes Relat Metab Disord. 2003;  27 ((3)) 385-388
  • 21 Nogueiras R, Wiedmer P, Perez-Tilve D. et al . The central melanocortin system directly controls peripheral lipid metabolism.  J Clin Invest. 2007;  117 ((11)) 3475-3488
  • 22 Notredame C, Higgins DG, Heringa J. T-Coffee: A novel method for fast and accurate multiple sequence alignment.  J Mol Biol. 2000;  302 ((1)) 205-217
  • 23 Ochoa MC, Azcona C, Biebermann H. et al . A novel mutation Thr162Arg of the melanocortin 4 receptor gene in a Spanish children and adolescent population.  Clin Endocrinol (Oxf). 2007;  66 ((5)) 652-658
  • 24 Ostman J, Britton M, Johnson E. eds. Treating and preventing obesity – an evidence based review. Wiley-VCH verlag Weinheim, Germany 2004
  • 25 Pollestad Kolsgaard ML, Andersen LF, Tonstad S. et al . Ethnic differences in metabolic syndrome among overweight and obese children and adolescents: the Oslo Adiposity Intervention Study.  Acta Paediatr. 2008 Jul 24;  , [Epub ahead of print]
  • 26 Rettenbacher E, Tarnow P, Brumm H. et al . A novel non-synonymous mutation in the melanocortin-4 receptor gene (MC4R) in a 2-year-old Austrian girl with extreme obesity.  Exp Clin Endocrinol Diabetes. 2007;  115 ((1)) 7-12
  • 27 Sonnhammer EL, Heijne G, Krogh A. A hidden Markov model for predicting transmembrane helices in protein sequences.  Proc Int Conf Intell Syst Mol Biol. 1998;  6 175-182
  • 28 Staubert C, Tarnow P, Brumm H. et al . Evolutionary aspects in evaluating mutations in the melanocortin 4 receptor.  Endocrinology. 2007;  148 ((10)) 4642-4648
  • 29 Tao YX, Segaloff DL. Functional analyses of Melanocortin-4 receptor mutations identified from patients with Binge eating disorder and nonobese or obese subjects.  J Clin Endocrinol Metab. 2005;  90 ((10)) 5632-5638
  • 30 Taylor MS, Ponting CP, Copley RR. Occurrence and consequences of coding sequence insertions and deletions in Mammalian genomes.  Genome Res. 2004;  14 ((4)) 555-566
  • 31 Vaisse C, Clement K, Durand E. et al . Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity.  J Clin Invest. 2000;  106 ((2)) 253-262
  • 32 Vaisse C, Clement K, Guy-Grand B. et al . A frameshift mutation in human MC4R is associated with a dominant form of obesity.  Nat Genet. 1998;  20 ((2)) 113-114
  • 33 Valli-Jaakola K, Lipsanen-Nyman M, Oksanen L. et al . Identification and characterization of melanocortin-4 receptor gene mutations in morbidly obese finnish children and adults.  J Clin Endocrinol Metab. 2004;  89 ((2)) 940-945
  • 34 Wang CL, Liang L, Wang HJ. et al . Several mutations in the melanocortin 4 receptor gene are associated with obesity in Chinese children and adolescents.  J Endocrinol Invest. 2006;  29 ((10)) 894-898
  • 35 Yeo GS, Farooqi IS, Aminian S. et al . A frameshift mutation in MC4R associated with dominantly inherited human obesity.  Nat Genet. 1998;  20 ((2)) 111-112

Correspondence

Dr. T. Wangensteen

Department of Medical Genetics

Ullevâl University Hospital

Kirkevn 166

0407 Oslo

Norway

Phone: +47/22/11 98 60

Fax: +47/22/11 98 99

Email: teresia.wangensteen@medisin.uio.no

    >